Effects of acute ketamine infusion on visual working memory encoding: a study using ERPs

Similar documents
Dr. Corinna Haenschel

Experimental Medicine and Psychiatry Drug Development. John H. Krystal, M.D. Yale University

Biomarkers in Schizophrenia

PERCEPTION: Gain Control & Integration. Mark A. Geyer, Ph.D. Departments of Psychiatry & Neurosciences University of California, San Diego

Lauren Harms 1,2,3, Ross Fulham 2,3,4, Juanita Todd 2,3,4, Ulrich Schall 2,3,5, Markku Penttonen 6, Deborah Hodgson 1,2,3, Patricia Michie 2,3,4

Angus W. MacDonald, III with Dori Henderson University of Minnesota Associate Professor of Psychology & Psychiatry

PSY/NEU338: Animal learning and decision making: Psychological, computational and neural perspectives

Thalamocortical Synchronization and Cognition: Implications for Schizophrenia?

Cognitive Neuroscience of Memory

Amino Acid Neurotransmitters. Paul Glue

Mirror Neurons in Primates, Humans, and Implications for Neuropsychiatric Disorders

Index. Index. More information

ESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal

Animal Models of Psychosis: Current State and Future Directions

Sensory Gating Measures. Auditory P50 Response Prepulse Inhibition of Startle (PPI) Bruce Turetsky, M.D. IOM Workshop June 22, 2010

The Neurobiology of Mood and Psychotic Disorders

Schizophrenia FAHAD ALOSAIMI

The Neurobiology of Psychiatric Disorders

Neural Correlates of Human Cognitive Function:

City, University of London Institutional Repository

Biomarkers Workshop In Clinical Trials Imaging for Schizophrenia Trials

Attention: Neural Mechanisms and Attentional Control Networks Attention 2

Biological Risk Factors

Pharmacological treatments for ASD

Brain and Cognition. Cognitive Neuroscience. If the brain were simple enough to understand, we would be too stupid to understand it

Outline. Outline. Background Literature and Slides 10/23/2013. The Schizophrenia Research Forum online: Molecules, Neural Networks and Behavior

Oscillations: From Neuron to MEG

Glutamate Overview. How can one neurotransmitter have so many diverse functions?

"The Drugs Don't Work" Eye Movements as Biomarkers in Psychopharmacology

BL-1020: First-in-Class GABA-Enhanced Antipsychotic For Schizophrenia

Physiology Unit 2 CONSCIOUSNESS, THE BRAIN AND BEHAVIOR

Tracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health

Do we still believe in the dopamine hypothesis? New data bring new evidence

Timing & Schizophrenia. Deana Davalos Colorado State University

Psychopharmacology 1: ECT

Physiological and Physical Basis of Functional Brain Imaging 6. EEG/MEG. Kâmil Uludağ, 20. November 2007

Neural model of emotional regulation structures - Circuits involving prefrontal cortex and subcortical limbic structures - MDE associated with

A Neural Circuitry Basis for the Core Clinical Features of Schizophrenia. Grand Needs and Challenges in Psychiatry

Studying the time course of sensory substitution mechanisms (CSAIL, 2014)

A Neural Circuitry Basis for the Core Clinical Features of Schizophrenia

Neurotransmitter Functioning In Major Depressive Disorder

Department of Psychiatry AG Stimulationsverfahren in der Psychiatrie. The Role of Ketamine in Treatment-Resistant Depression

Computational Neuropharmacology

Psychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003

Patients with disorders of consciousness: how to treat them?

SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009

Transcranial direct current stimulation modulates shifts in global/local attention

On the nature of Rhythm, Time & Memory. Sundeep Teki Auditory Group Wellcome Trust Centre for Neuroimaging University College London

Use of Functional Brain Circuitry for Diagnostic and Treatment Decisions

Physiology Unit 2 CONSCIOUSNESS, THE BRAIN AND BEHAVIOR

The outlook for schizophrenia is better than we think but is being sabotaged by Assembly-line Psychiatry

EEG Analysis on Brain.fm (Focus)

Thinking Outside the Box: Prescribing by Synthesis & Integration

Mental State Sensing and the Goal of Circuit-Synapse Synergy

CHAPTER 3. Schizophrenia and Antipsychotic Treatment

Schizophrenia update for GPs. Prof Douglas Turkington.

Schizophrenia Battery

Developmental regulation of Medium Spiny Neuron dendritic arborization. Lorene M. Lanier Department of Neuroscience

Evidence for false memory before deletion in visual short-term memory

Effects of Ketamine on Healthy Participants and Individuals Suffering from Schizophrenia. John Smith. Physiological Foundations of Psychology 71733

Psychopathology: Biological Basis of Behavioral Disorders

SAMPLE EXAMINATION QUESTIONS

22 JWA :00-15:

Disorders of the Brain Systems

Biomedical Research 2013; 24 (3): ISSN X

Introduction to Electrophysiology

Office Management of Patients Living With Schizophrenia

Clinical Use of Ketamine in Psychiatry

How to Build a Cognitive Task

Spectral fingerprints of large-scale neuronal interactions

Identifying Youth at Clinical High Risk for Psychosis

Basal Ganglia General Info

Retrieval Success and the Prefrontal Cortex Evidence from fmri

- Neurotransmitters Of The Brain -

Manuscript under review for Psychological Science. Direct Electrophysiological Measurement of Attentional Templates in Visual Working Memory

Attentional Blink Paradigm

Glycine Ingredient in Productive Sleep

Final Report 2017 Authors: Affiliations: Title of Project: Background:

Neurofunctional Characterization of the At- Risk Mental State for Psychosis. Elizabeth Johnson Sumner. Department of Neurobiology Duke University

Are they still doing that?

Prefrontal cortex. Executive functions. Models of prefrontal cortex function. Overview of Lecture. Executive Functions. Prefrontal cortex (PFC)

The Neuroscience of Addiction: A mini-review

Beyond Blind Averaging: Analyzing Event-Related Brain Dynamics. Scott Makeig. sccn.ucsd.edu

Electrophysiological evidence of two different types of error in the Wisconsin Card Sorting Test

The Role of Oscillations and Synchrony in Cortical Networks and Their Putative Relevance for the Pathophysiology of Schizophrenia

Summary. Multiple Body Representations 11/6/2016. Visual Processing of Bodies. The Body is:

Pharmacological Managment of Treatment Resistant Schizophrenia. Jean-Marie Batail - France 21 st July 2015

Schizophrenia & the Antipsychotics

Material-speci c neural correlates of memory retrieval

Dysconnectivity, Large-Scale Networks and Neuronal Dynamics in Schizophrenia

The Nervous System. Neuron 01/12/2011. The Synapse: The Processor

Potential Treatment and Current Research in Phelan-McDermid Syndrome. 11/16/2016 Frambu Center for Rare Disorders

AUXILIARIES AND NEUROPLASTICITY

Classes of Neurotransmitters. Neurotransmitters

UNIVERSITY OF BOLTON SCHOOL OF EDUCATION AND PSYCHOLOGY PSYCHOLOGY PATHWAYS SEMESTER 2 EXAMINATIONS 2015/2016

The role of amplitude, phase, and rhythmicity of neural oscillations in top-down control of cognition

Your support makes a vast difference to the success of our research and the health of our community.

Theories of Schizophrenia. Dr Bharat Shah

LEIGH GAYLE GOETSCHIUS

The Cerebral Cortex and Higher Intellectual Functions

Transcription:

Effects of acute ketamine infusion on visual working memory encoding: a study using ERPs Corinna Haenschel Psychology, City University London, UK Partly Funded by: the Welsh Institute of Cognitive Neuroscience

Schizophrenia: The relevance of cognitive deficits for the understanding of schizophrenia Schizophrenia is associated with acute psychiatric symptoms (i.e. hallucinations, delusions). Even when free of these symptoms (which is most of the time), patients suffer from severe problems in day to day life resulting in tremendous personal and economic costs. These appear to be highly related to cognitive deficits associated with the disorder. Working Memory is one of the most fundamental processes in performing many daily tasks. Impaired Visual Working memory (WM) is a core deficit in schizophrenia. Treating WM impairments may have important practical benefits for patients (both behaviourally and with drugs).

Impaired visual working memory (WM) is a core deficit in schizophrenia

Visual working memory deficits in schizophrenia: Evidence from fmri and EEG Encoding Maintenance Retrieval FEF IPS DLPFC VLPFC Visual cortex WM deficits have mostly been attributed to maintenance and executive functions associated with prefrontal cortical dysfunction. More recently emphasis on the encoding stage of WM and possible deficits occurring at this stage.

Delayed Discrimination Task

Estimated Number of Stored Items Behavioural data: Early Onset Sz Reaction Time 1300 1200 NC SCZ ms 1100 1000 900 800 3 2.5 L1 L2 L3 Number of encoded stimuli 2 1.5 NC SCZ 1 0.5 Load 1 Load 2 Load 3 Haenschel et al., 2007,

% WM Performance in the SZ-spectrum Early Onset Sz Chronic Sz Schizotypy 100 Accuracy Controls 95 90 85 80 1 2 3 Load Haenschel et al., 2007, Koychev et al. 2010; 2012

ERPs: The importance of Encoding for successful WM and its Dysfunctions P1 ERP component increases with load predicting performance in controls but is severely reduced in early onset schizophrenia. Haenschel et al., Arch Gen Psych 2007

ERPs: P1 as a biomarker of the disorder? P1 ERP component increases with load predicting performance in controls fmri revealed reduced activation in the middle occipital gyrus in early onset schizophrenia. but is severely reduced in early onset schizophrenia. Haenschel et al., Arch Gen Psych 2007,

Functional connectivity between frontal and visual areas during Encoding Reduced functional connectivity between left VLPFC and the left LOC & between right extrastriate visual cortex and left early visual cortex in patients! Bittner, Linden, Haenschel, 2014

Neurochemical background of WM encoding? Disturbances in Dopamine, GABA, Glutamate (NMDA receptors) have been found in schizophrenia. Glu/ /ERPs DA Lewis: http://www.ccnmd.pitt.edu/pages/research/researchov.html

Ketamine Ketamine is a well-established pharmacological model of schizophrenia This has been attributed to its NMDA antagonism and likely involves disinhibition of glutamatergic pyramidal neurons and consequent downstream dysregulation of the striatal dopamine system. Question: Will ketamine reproduce both the working memory and visual information processing deficits?

Methods: WM & EEG Randomised & Blind: Continuous Intravenous infusion of placebo (0.9% normal saline) or Ketamine (100ng/ml) Infusion randomised by Pharmacy. After 5 Min Infusion 2 WM runs 2 Min Rest & CADS 2 WM runs Rest & BPRS 2 WM runs CADS: Clinician Administered Dissociative Symptom Scale; BPRS: Brief Psychiatric Rating scale

Methods EEG ketamine Koychev, Deakin, El-Deredy, Haenschel, in prep.

Mean percentage correct Reaction times (ms) Behavioural results 44 healthy volunteers (22 ketamine, 22 placebo) 100 Percentage correct WM task Ketamine Placebo Reaction times WM task 95 1200 90 85 1100 80 1000 75 WM load 1 WM load 2 WM load 3 900 WM load 1 WM load 2 WM load 3 Group effect: Clinician Administered Dissociative States Scale (CADSS): p=0.005 & BPRS: p=.006 Koychev, Deakin, El-Deredy, Haenschel, in prep.

Amplitude (µv) Results: ERP occipital electrodes 5 Ketamine 4 Placebo 3 * 2 1 0-1 -400-200 0 200 400 600 800 1000 Time (ms) * F(1,42) = 6.673, p =.04; partial eta 2 = 0.1 Koychev, Deakin, El-Deredy, Haenschel, in prep.

Amplitude (microvolts) Amplitude (microvolts) Effects of acute Ketamine on WM encoding P1 amplitude encoding 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 WM load 1 WM load 2 WM load 3 P300 amplitude encoding Placebo Ketamine Increase in P1 3.0 2.5 2.0 1.5 1.0.5.0 WM load 1 WM load 2 WM load 3 But a later decrease in P300 Koychev, Deakin, El-Deredy, Haenschel, in prep.

Discussion Ketamine induces cognitive impairment similar to the one found in psychosis and schizotypy Early visual evoked responses are however augmented Later EEG components (P300) are significantly reduced in amplitude Visual cortex disinhibition caused by ketamine associated with higher order disturbance?

Acknowledgements IOP

Thank you for your attention!

P1 as a biomarker: SCHIZOTYPY Koychev et al. Neuropsychologia 2010 Jun;48(7):2205-14

Glutamate Level (mm) Glutamate Level (mm) a b c d 19 14 Object Stimuli 17 16 15 14 13 12 11 10 Glutamate level Stimulus Object Abstract 9 4-0.06-0.04-0.02 0 0.02 0.04 0.06 0.08 19 14 Abstract Stimuli 9 4-0.06-0.04-0.02 0 0.02 0.04 0.06 0.08 Evoked Gamma-Band Activity (μv)

Combining measures of electrophysiology and neurotransmitters in humans? Different ways of investigating possible relationship Use measures of EEG/MEG and MRspectroscopy to measure neurotransmitter concentration (Lally et al., 2014) Using drugs that block or enhance specific transmitters, for example ketamine, a NMDA antagonists

Methods The influence of ketamine on WM using EEG. Participants were randomised to receive an intravenous infusion of placebo (0.9% normal saline) or Ketamine. Ketamine was administered to achieve a dose of 100ng/ml